Anirban Maitra: The highest cited publication overall is a review on Pancreatic Cancer
Anirban Maitra, Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center, shared a post on X:
“First, the highest cited publication overall (not surprisingly) is a review on Pancreatic Cancer published in The Lancet by Rachna Shroff, Jon Mizrahi et al. in 2020 (cited >2100 times).
Followed by a review in JAMA by Eileen M O’Reilly, Wungki Park et al. published in 2021, cited >1200 times. Both outstanding foundational reviews on the subject!”
Authors: Jonathan Mizrahi, Rishi Surana, Juan Valle,
Authors: Wungki Park,Akhil Chawla, Eileen O’Reilly.
Rachna Shroff, Associate Director of Clinical Investigations at the University of Arizona Cancer Center, shared this post, adding:
“Ok, this is actually pretty cool. Thanks for pointing it out Anirban Maitra!”
Dr. Anirban Maitra serves as a Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center since August 2013, and directs the Sheikh Ahmed Pancreatic Cancer Research Center.
He leads an NCI-funded laboratory dedicated to pancreatic cancer research, focusing on genetics and molecular pathology in human and mouse models. His research aims to advance early detection and interception strategies to enhance patient survival rates in pancreatic cancer.
Rachna Shroff is an Associate Director of Clinical Investigations and co-leader of the Gastrointestinal Clinical Research Team at the University of Arizona Cancer Center (UACC).
She also is a professor with tenure in the Department of Medicine, the Chief of the Division of Hematology and Oncology, the Medical Director for the Oncology Service Line, and the Associate Dean for Clinical and Translational Research for the University of Arizona College of Medicine – Tucson.
Prof. Shroff is the Hepatobiliary Subcommittee co-chair for the Southwest Oncology Group (SWOG), Chair for GI ASCO 2024, and member of the ASCO Nominating Committee. Her clinical and research focus is the development of novel therapies for pancreatic and hepatobiliary cancers.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023